Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesterol Ester Transfer Protein (CETP) in Type-1 Diabetes Patients

NCT02816099 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT02816099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesterol Ester Transfer Protein (CETP) in Type-1 Diabetes Patients
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2014
Completion date
November 14, 2022
Enrollment
206 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabète de type 1